Dr. Stephen Russell Chen, MD

Dr. Chen practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Chen's NPI, 1396798500, was assigned on May 18, 2006. Dr. Chen graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 2000. Dr. Chen holds Texas license M5098.

Dr. Chen's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Chen's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Chen is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Chen's licenses on file in 11 states: Texas, Florida, Georgia, Washington, Alabama, Arizona, Louisiana, Mississippi, Oklahoma, Tennessee and Indiana.

CMS data shows 312 Medicare services from Dr. Chen across 11 procedure codes in 2024, for 187 Medicare patients. Medicare paid $33,981 for them.

CMS counts 187 Medicare patients who saw Dr. Chen in 2024. The largest group is 65 to 74, with 110 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 67, with 39% women.

In 2024, Dr. Chen wrote 35 Medicare Part D claims for 17 patients. 89% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $91 in total drug cost. In 2023, CMS named 44 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Chen for performance year 2024, reported as part of a group. Dr. Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chen as offering telehealth.

Dmand AI links 38 papers to Dr. Chen, published from 2016 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Embolization, Therapeutic, Endovascular Procedures and Stents. Dr. Chen has published most often in J Neurointerv Surg. Dr. Chen's most frequent co-authors are Peter T. Kan, MD, Joshua David Kuban, MD, MMSC and Frederick F. Lang, MD.

CMS Open Payments shows 138 general payments to Dr. Chen from 30 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 36% of the total. Blockade Medical, LLC paid the most, $10,535.

Dmand AI lists 2 awards for Dr. Chen, most recently Alpha Omega Alpha in 2019.

Dr. Chen graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 2000. Dr. Chen is a member of International Society of Ocular Oncology, SIR, Society of NeuroInterventional Surgery and World Federation for Interventional and Therapeutic Neuroradiology.

Dr. Chen is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.